Dr. Bruce E. Johnson is a highly experienced medical oncologist who received his MD from the University of Minnesota in 1979. He completed his postgraduate training at the University of Chicago and the National Cancer Institute (NCI), where he most recently headed the Lung Cancer Biology Section. He joined Dana-Farber Cancer Institute (DFCI) in 1999 and is currently co-leads the Dana-Farber/Harvard Cancer Center Lung Cancer Program.

Dr. Johnson has held several leadership positions throughout his career, including Chief Clinical Research Officer at DFCI and a Senior Consultant on the Executive Leadership Team. He is Board certified in internal medicine, nephrology, and medical oncology. He is also an award-winning researcher, having received the ASCO Cancer Foundation Translational Research Professorship from 2008-2013, and he has been elected to the Association of American Physicians in 2015.

Dr. Johnson's clinical interests include genomic characterization, mesothelioma, non-small cell lung cancer, and small cell lung cancer. His primary location is Dana-Farber Cancer Institute, located at 450 Brookline Avenue, Dana 1234, Boston, MA 02215. The phone number is 617-632-6190.